These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 20739514)

  • 1. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model.
    Bente DA; Alimonti JB; Shieh WJ; Camus G; Ströher U; Zaki S; Jones SM
    J Virol; 2010 Nov; 84(21):11089-100. PubMed ID: 20739514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.
    Hawman DW; Meade-White K; Haddock E; Habib R; Scott D; Thomas T; Rosenke R; Feldmann H
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31292241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.
    Lindquist ME; Zeng X; Altamura LA; Daye SP; Delp KL; Blancett C; Coffin KM; Koehler JW; Coyne S; Shoemaker CJ; Garrison AR; Golden JW
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside-Modified mRNA Vaccines Protect IFNAR
    Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
    J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy.
    Zivcec M; Safronetz D; Scott D; Robertson S; Ebihara H; Feldmann H
    J Infect Dis; 2013 Jun; 207(12):1909-21. PubMed ID: 23417661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever.
    Rodriguez SE; Cross RW; Fenton KA; Bente DA; Mire CE; Geisbert TW
    Sci Rep; 2019 May; 9(1):7755. PubMed ID: 31123310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.
    Hawman DW; Meade-White K; Leventhal S; Feldmann F; Okumura A; Smith B; Scott D; Feldmann H
    Elife; 2021 Jan; 10():. PubMed ID: 33416494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hazara virus infection is lethal for adult type I interferon receptor-knockout mice and may act as a surrogate for infection with the human-pathogenic Crimean-Congo hemorrhagic fever virus.
    Dowall SD; Findlay-Wilson S; Rayner E; Pearson G; Pickersgill J; Rule A; Merredew N; Smith H; Chamberlain J; Hewson R
    J Gen Virol; 2012 Mar; 93(Pt 3):560-564. PubMed ID: 22090213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
    Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice.
    Bereczky S; Lindegren G; Karlberg H; Akerström S; Klingström J; Mirazimi A
    J Gen Virol; 2010 Jun; 91(Pt 6):1473-7. PubMed ID: 20164263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in understanding Crimean-Congo hemorrhagic fever virus.
    Hawman DW; Feldmann H
    F1000Res; 2018; 7():. PubMed ID: 30416710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
    Hawman DW; Haddock E; Meade-White K; Williamson B; Hanley PW; Rosenke K; Komeno T; Furuta Y; Gowen BB; Feldmann H
    Antiviral Res; 2018 Sep; 157():18-26. PubMed ID: 29936152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38.
    Mishra AK; Moyer CL; Abelson DM; Deer DJ; El Omari K; Duman R; Lobel L; Lutwama JJ; Dye JM; Wagner A; Chandran K; Cross RW; Geisbert TW; Zeitlin L; Bornholdt ZA; McLellan JS
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31996434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
    Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of Crimean-Congo hemorrhagic fever.
    Akıncı E; Bodur H; Leblebicioglu H
    Vector Borne Zoonotic Dis; 2013 Jul; 13(7):429-37. PubMed ID: 23663164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice Models.
    Aligholipour Farzani T; Földes K; Hanifehnezhad A; Yener Ilce B; Bilge Dagalp S; Amirzadeh Khiabani N; Ergünay K; Alkan F; Karaoglu T; Bodur H; Ozkul A
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean-Congo hemorrhagic fever virus.
    Wang Q; Cao R; Li L; Liu J; Yang J; Li W; Yan L; Wang Y; Yan Y; Li J; Deng F; Zhou Y; Wang M; Zhong W; Hu Z
    Antiviral Res; 2022 Mar; 199():105273. PubMed ID: 35257725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosis.
    Smith DR; Shoemaker CJ; Zeng X; Garrison AR; Golden JW; Schellhase CW; Pratt W; Rossi F; Fitzpatrick CJ; Shamblin J; Kimmel A; Zelko J; Flusin O; Koehler JW; Liu J; Coffin KM; Ricks KM; Voorhees MA; Schoepp RJ; Schmaljohn CS
    PLoS Pathog; 2019 Sep; 15(9):e1008050. PubMed ID: 31557262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice.
    Welch SR; Ritter JM; McElroy AK; Harmon JR; Coleman-McCray JD; Scholte FEM; Kobinger GP; Bergeron É; Zaki SR; Nichol ST; Spengler JR; Spiropoulou CF
    PLoS Pathog; 2019 Dec; 15(12):e1008183. PubMed ID: 31790513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.